Spire Healthcare Group (LON:SPI)‘s stock had its “sell” rating reissued by analysts at Berenberg Bank in a note issued to investors on Tuesday, September 18th. They presently have a GBX 120 ($1.57) price target on the stock. Berenberg Bank’s price target would suggest a potential downside of 4.61% from the company’s previous close.
Several other research firms also recently weighed in on SPI. Liberum Capital restated a “hold” rating on shares of Spire Healthcare Group in a research report on Tuesday, July 17th. Peel Hunt restated an “add” rating on shares of Spire Healthcare Group in a research report on Tuesday, July 17th. JPMorgan Chase & Co. decreased their target price on Spire Healthcare Group from GBX 293 ($3.83) to GBX 256 ($3.35) and set a “neutral” rating on the stock in a research report on Tuesday, August 7th. Credit Suisse Group upgraded Spire Healthcare Group to a “neutral” rating and decreased their target price for the company from GBX 250 ($3.27) to GBX 215 ($2.81) in a research report on Wednesday, August 8th. Finally, Numis Securities decreased their target price on Spire Healthcare Group from GBX 296 ($3.87) to GBX 280 ($3.66) and set a “buy” rating on the stock in a research report on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of GBX 189 ($2.47).
Shares of LON SPI traded down GBX 0.20 ($0.00) during midday trading on Tuesday, hitting GBX 125.80 ($1.64). The stock had a trading volume of 2,455,776 shares, compared to its average volume of 1,770,000. Spire Healthcare Group has a 1 year low of GBX 206.40 ($2.70) and a 1 year high of GBX 362.10 ($4.73).
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Read More: Hedge Funds
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.